NaveniFlexTM BOND RX Atto647N Reference: 60009 Detect proteins, protein – protein interactions, or protein modifications with Naveni® in situ technology using BOND RX/RXm Fully Automated Research Stainer. The kit should be used with the user’s primary antibodies of choice (raised in mouse and rabbit). Detection with Atto647N fluorophore is included.
Emactuzumab Reference: HY-P99245 Emactuzumab(RG 7155) is a specific monoclonal antibody that inhibits colonystimulating factor 1 receptor (CSF1R) activation. Emactuzumab has high affinity for CSF-1R with Ki value of 0.2 nM to blocks CSF-1R dimerization. Emactuzumab can be used for the research of several diseases, such as diffuse-type tenosynovial giant cell tumour (dt-GCT) .
NaveniFlexTM BOND RX RED Reference: 60010 Detect proteins, protein – protein interactions, or protein modifications with Naveni® in situ technology using BOND RX/RXm Fully Automated Research Stainer. The kit should be used with the user’s primary antibodies of choice (raised in mouse and rabbit). Detection with Texas Red fluorophore is included.
Sacituzumab Reference: HY-P99045 Sacituzumab is a humanized IgG1 monoclonal antibody for anti-trophoblast cell-surface antigen 2 (anti-Trop-2). Sacituzumab has the potential for metastatic triple-negative breast cancer research.
Naveni PD1/PDL1 BOND RX Atto647N Reference: 60011 Visualize the interaction of PD1/PD-L1 in situ using BOND RX/RXm Fully Automated Research Stainer. Detection with Atto647N fluorophore is included.
Abagovomab Reference: HY-P99276 Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal anti-idiotypic antibody, against the tumor-associated antigen, CA-125. Abagovomab is generated by a mouse hybridoma, can imitate the human TAA, CA-125. Abagovomab can elicit humoral and cellular immune responses against ovarian cancer (oc).
Naveni PD1/PDL1 BOND RX RED Reference: 60012 Visualize the interaction of PD1/PD-L1 in situ using BOND RX/RXm Fully Automated Research Stainer. Detection with Texas Red fluorophore is included.
Nirsevimab Reference: HY-P99756 Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with modified Fc region, which can prolong its half-life. Nirsevimab has an affinity for RSV-B with an Kd value of 1.5 nM. Nirsevimab can be used for RSV research.
Naveni Plex Reference: 60000 Naveni® Plex enables the simultaneous detection of 3 separate targets or protein-protein interactions, with enhanced specificity and sensitivity using multiplex in situ proximity ligation assay. The kit has been validated on FFPE human tissue samples and provides a fluorescent readout.
Tildrakizumab Reference: HY-P99256 Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 (Kd: 136 pM). Tildrakizumab is effective against moderate to severe plaque psoriasis.
Asc (AL177) Antibody + Blocking Peptide Set Reference: AG-44B-2000 The Asc (AL177) Antibody + Blocking Peptide Set contains one vial each of the anti-Asc, pAb (AL177) (Prod. No. AG-25B-0006) and the Asc Antibody (AL177) Blocking Peptide (Prod. No. AG-37B-0001). Both compounds are provided with the appropriate product datasheet including additional product information.
Eptinezumab Reference: HY-P99017 Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults.